Allergan Plc (AGN) SEC Filing 8-K Material Event for the period ending Wednesday, May 6, 2020

Allergan Plc

CIK: 1578845 Ticker: AGN

View differences made from one to another to evaluate Allergan Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Allergan Plc.


Assess how Allergan Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Allergan Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Allergan Plc provided additional information to their SEC Filing as exhibits

Ticker: AGN
CIK: 1578845
Form Type: 8-K Corporate News
Accession Number: 0001193125-20-134315
Submitted to the SEC: Wed May 06 2020 7:17:29 AM EST
Accepted by the SEC: Wed May 06 2020
Period: Wednesday, May 6, 2020
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: